NCT00120705View on ClinicalTrials.gov

Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

September 30, 2003

Conditions
NeoplasmsAnemia
Interventions
DRUG

darbepoetin alfa

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY